Bioventus Inc. Class A Common Stock

$8.910
USD
Last updated on --.
24h volume964.78K
24h highest9.4690 USD
24h lowest8.3850 USD
24h Price movement-1.22%

BVS recent prices

24 Hours
-1.22%-$0.11
30 days
-10.54%-$1.050
60 days
-0.56%-$0.05
90 days
+1.48%+$0.13

Key data

Previous close9.0200 USD
Market cap741.16M USD
Volume964.78K
P/E ratio26.020000
Dividend yield (TTM)0.00%
Dividend amount0.61000 USD
Next ex-dividend date26 Mar 2004
Next payment date31 Mar 2004
EPS diluted (TTM)0.42000 USD
Net income (FY)34.54M USD
Revenue (FY)576.30M USD
Last report date6 May 2026

About Bioventus Inc. Class A Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
HeadquartersDURHAM
Employees (FY)940.00
Revenue per employee (FY)613.09K USD
Net income per employee (FY)36.75K USD
Listed onNasdaq
Official website

BVS conversion tables

BVSBVS
USDUSD
0.5 BVS4.455 USD
1 BVS8.910 USD
5 BVS44.55 USD
10 BVS89.1 USD
USDUSD
BVSBVS
0.5 USD0.056117 BVS
1 USD0.11223 BVS
5 USD0.56117 BVS
10 USD1.122 BVS

FAQ

BVS is trading at $8.910, -1.22% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BVS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BVS is currently trading at $8.910, -1.22% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BVS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BVS's P/E ratio is currently 26.020000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BVS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BVS's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Bioventus Inc. Class A Common Stock's market cap is currently 741.16M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume964.78K
24h highest9.4690 USD
24h lowest8.3850 USD
24h Price movement-1.22%
BVSBVS
USDUSD
Start trade with BVS Perpetual